Logo.png
Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies - Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma
April 09, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, April 09, 2024 (GLOBE NEWSWIRE) -- Treatment-Resistant Hypertension Market is Anticipated to Showcase Immense Growth by 2032, Predicts DelveInsight | Key Companies - Idorsia, Janssen...
Logo.png
Propulsion of Hypertriglyceridemia Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight
August 14, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Propulsion of Hypertriglyceridemia Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight The...
Logo.png
Fallopian Tube Cancer Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
November 14, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Fallopian Tube Cancer Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Abnormal...
Logo.png
Primary Myelofibrosis Pipeline Space Brims With Novel Emerging Therapies with Over 50 Key Companies Working in the Domain | DelveInsight
November 07, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Primary Myelofibrosis Pipeline Space Brims With Novel Emerging Therapies with Over 50 Key Companies Working in the Domain | DelveInsight Primary...
Logo.png
Treg Cell-based Therapies Pipeline Landscape Analysis of 22+ Companies by DelveInsight
September 26, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Treg Cell-based Therapies Pipeline Landscape Analysis of 22+ Companies by DelveInsight Given the various benefits offered, including high target...